Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]Sabine D Allard,Brenda De Keersmaecker,Anna De Goede,Esther J Verschuren,Jeanette Koetsveld,Mariska L Reedijk,Carolien Wylock,Annelies De Bel,Judith Vandeloo,Frank H M Pistoor,Carlo Heirman,Walter Beyer,Paul H C Eilers,Jurgen Corthals,Iman Padmos,Kris Thielemans, Ab Osterhaus,Patrick Lacor,Marchina Van Der Ende,Joeri Aerts,Carel Van Baalen,Rob A GrutersClinical Immunology(2014)引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要